* Treace Medical Concepts Inc TMCI.OQ reported a quarterly
adjusted loss of 12 cents per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for breakeven results per share.
* Revenue was $33.44 million; analysts expected $32.27
million.
* Treace Medical Concepts Inc's reported EPS for the quarter
was a
loss of 12 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Treace Medical Concepts Inc shares had risen by 10.9% this
quarter.
* The company reported a quarterly loss of $6.62 million.
* Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $31.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated March 4 at 04:43 a.m. All
figures in US dollars unless otherwise stated